Cardiac arrhythmias in the human fetus

Pediatric Cardiology

Volumn 25, Issue 3, 2004, Pages 234-251

  Kleinman, C S ^a,b   Nehgme, R A ^c,d  

^a Weill Med Coll of Cornell Univ ^*  (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Cardiac arrhythmias; Fetal arrhythmias; Fetal cardiology; Fetal heart; Fetal physiology; Fetal therapy; Hydrops fetalis

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; AUTOANTIBODY; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CISAPRIDE; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DIGITALIS GLYCOSIDE; DIGOXIN; ERYTHROMYCIN; FLECAINIDE; KETOCONAZOLE; LA ANTIBODY; PROPRANOLOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RO ANTIBODY; SOTALOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ALGORITHM; ARTIFICIAL HEART PACEMAKER; AUTOIMMUNE DISEASE; BRADYCARDIA; COMPLETE HEART BLOCK; CONGENITAL HEART MALFORMATION; EXTRASYSTOLE; FETUS; FETUS HYDROPS; FETUS MONITORING; HEART ARRHYTHMIA; HEART RHYTHM; HUMAN; PATHOPHYSIOLOGY; REVIEW; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA;

EID: 2642582540     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-003-0589-x     Document Type: Review

References (51)

1. Anandakumar C, Biswas A, Chew SS, et al. (1996) Direct fetal therapy for hydrops secondary to congenital atrioventricular heart block. Obstet Gynecol 87:835-837
2. Anderson PAW (1996) The heart and development. Sem Perinatolo 20:482-509
3. Assad RS, Jatene MB, Moreira LF, et al. (1994) Fetal heart block: a new experimental model to assess fetal pacing. Pacing Clin Electrophysiol 17:1256-1263
4. Better DJ, Kaufman S, Allan LD (1996) The normal pattern of pulmonary venous flow on pulsed Doppler examination of the human fetus. J Am Soc Echocardiogr 9:281-285
5. Carpenter RJ, Strasburger JF, Garson Jr A, et al. (1986) Fetal ventricular pacing for hydrops secondary to complete atrioventricular block. J Am Coll Cardiol 8:1434-1436
6. Copel JA, Buyon JP, Kleinman CS (1995) Successful in utero therapy of fetal heart block. Am J Obstet Gynecol 173:1384-1390
7. Copel JA, Liang RI, Demasio K, Ozeren S, Kleinman CS (2000) The clinical significance of the irregular fetal heart rhythm. Am J Obstet Gynecol 182:813-817
8. DeWolff D, deSchepper J, Verhaaren H, et al. (1988) Congenital hypothyroid goiter and amiodarone. Acta Paediatr Scand 77:616-618
9. Evans MI, Pryde PG, Reichler A, et al. (1993) Fetal drug therapy. Western J Med 159:325-332
10. Friedman WF (1993) The intrinsic physiologic properties of the developing heart. In: Friedman WF, Lesch M, Sonnenblick EH (Eds.), Neonatal Heart Disease. Grune & Stratton, New York, pp 87-111
11. Garson A (1987) Medicolegal problems in the management of cardiac arrhythmias in children. Pediatrics 79:84-88
12. Gillette PC (1980) The mechanisms of supraventricular tachycardia in children. Circulation 54:133-139
13. Gladstone GR, Hordof A, Gersony WM (1975) Propranolol administration during pregnancy: effects on the fetus. J Pediatr 86:962-964
14. Hansmann M, Gembruch U, Bald RK, et al. (1991) Fetal tachyarrhythmias: transplacental and direct treatment of the fetus. A report of 60 cases. Ultrasound Obstet Gynecol 1:162-167
15. Harris JP, Alexson CG, Manning JA, Thompson HO (1993) Medical therapy for the hydropic fetus with congenital complete atrioventricular block. Am J Perinatol 10:217-219
16. Horsfall AC, Li JM, Maini RN (1996) Placental and fetal cardiac laminin are targets for cross-reacting autoantibodies from mothers of children with congenital heart block. J Autoimmun 9:561-568
17. Kikuchi Y, Shiraisi H, Igarashi H, et al. (1995) Cardiac pacing in fetal lambs: Intrauterine transvenous cardiac pacing for fetal complete heart block. Pacing Clin Electrophysiol 18:417-423
18. Kleinman CS, Copel JA (1992) Fetal cardiovascular physiology and therapy. Fetal Diagn Ther 7:147-157
19. Kleinman CS, Copel JA, Nehgme RA (2001) The fetus with cardiac arrhythmia. In: Harrison MR, Evans MI, Adzick NS, Holzgreve W (Eds.), The Unborn Patient: The Art and Science of Fetal Therapy. Saunders, Philadelphia, pp 417-441
20. Kleinman CS, Donnerstein RL, DeVore GR, et al. (1982) Fetal echocardiography for evaluation of in utero congestive heart failure: a technique for study of nonimmune fetal hydrops. N Engl J Med 306:568-575
21. Kleinman CS, Donnerstein RL, Jaffe CC, et al. (1983) Fetal echocardiography. A tool for evaluation of in utero cardiac arrhythmias and monitoring of in utero therapy: analysis of 71 patients. Am J Cardiol 51:237-243
22. Kleinman CS, Dubin AM, Nehgme RA (1999) Left atrial tachycardia in the human fetus: identifying the fetus at greatest risk for developing nonimmune hydrops fetalis. Proceedings of the Second World Congress of Pediatric Cardiology and Cardiac Surgery. Futura, Armonk, NY,
23. Kleinman CS, Hobbins JC, Jaffe CC, et al. (1980) Echocar-diographic studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias. Pediatrics 65:1059-1067
24. Kleinman CS, Nehgme RA, Copel JA (1988) Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy RK, Resnik R (Eds.), Maternal Fetal Medicine. 4th ed: Saunders, Philadelphia, pp 301-318
25. Kolke T, Minakami H, Shiraishi H, Sato I (1997) Fetal ventricular rate in case of congenital complete heart block is increased by ritodrine. Case report. J Perinat Med 25:216-218
26. Krapp M, Gembruch U, Baumann P (1997) Venous blood flow pattern suggesting tachycardia-induced "cardiomyopathy" in the fetus. Ultrasound Obstet Gynecol 10:32-40
27. Mahony L (1996) Calcium homeostasis and control of contractility in the developing heart. Sem Perinatol 20:510-519
28. Michaelsson M, Engle MA (1972) Congenital complete heart block: an international study of the natural history. Cardiovascular Clin 4:85-101
29. Morganroth J (1987) Risk factors for the developfnent of proarrhythmic events. Am J Cardiol 59:32E-37E
30. Mrotsuki J, Okamura K, Watanabe T, et al. (1995) Production of complete heart block and in utero cardiac pacing in fetal lambs. J Obstet Gynaecol 21:223-239
31. Naheed ZJ, Strasburger JF, Deal BJ, et al. (1996) Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 27:1736-1740
32. Nimrod C, Davies D, Harder J, et al. (1987) Ultrasound evaluation of tachycardia-induced hydrops in the fetal lamb. Am J Obstet Gynecol 57:655-661
33. Physician's Desk Reference (2003) Medical Economics, Montvale, NJ
34. Rasheed A, Simpson J, Rosenthal E (2003) Neonatal EGG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia. Heart 89:470
35. Reed KL, Appleton CP, Anderson CF, et al. (1990) Doppler studies of vena cava flows in human fetuses. Insights into normal and abnormal cardiac physiology. Circulation 81:498-505
36. Roden DM (1994) Risks and benefits of antiarrhythmic therapy. N Engl J Med 305:785-791
37. Rogers MC, Willerson JT, Goldblatt A, Smith TW (1972) Serum digoxin concentrations in the human fetus, neonate and infant. N Engl J Med 287:1010-1014
38. Rudolph AM (2001) Congenital Diseases of the Heart, 2nd edn. Futura, Armonk, NY
39. Rudolph AM, Heymann MA (1976) Cardiac output in the fetal lamb: the effect of spontaneous and induced changes of heart rate on the right and left ventricular output. Am J Obstet Gynecol 124:183-189
40. Schmidt KG, Ulmer HE, Silverman NH, et al. (1991) Perinatal outcome of fetal congenital complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 17:1360-1366
41. Silverman NH, Kleinman CS, Rudolph AM, et al. (1985) Fetal atrioventricular valve insufficiency associated with nonimmune hydrops. A two-dimensional echocardiography and pulsed Doppler ultrasound study. Circulation 72:825-831
42. Simpson JM, Milburn A, Yates RW, et al. (1997) Outcome of intermittent tachyarrhythmias in the fetus. Pediatr Cardiol 18:78-82
43. Simpson LL, Marx GR, D'Alton ME (1997) Supraventricular tachycardia in the fetus: conservative management in the absence of hemodynamic compromise. J Ultrasound Med 16:459-464
44. Van Leeuwen P, Schussler, et al. (1995) Magnetocardiography for assessment of fetal heart actions. Geburtshilfe Fruaenheilkd 55:642-646
45. Walkinshaw SA, Welch CR, McCormack J, et al. (1994) In utero pacing for congenital hart block. Fetal Diagn Ther 9:183-185
46. Walsh EP (2001) Clinical approach to diagnosis and acute management of tachycardias in children. In: Walsh EP, Saul JP, Triedman JK (Eds.), Cardiac Arrhythmias in Chilren Young Adults with Congenital Heart Disease. Lippincott Williams & Wilkins, Philadelphia, pp 95-113
47. Ward RM (1995) Pharmacological treatment of the fetus: clinical pharmacokinetic considerations. Clin Pharmacokinet 28:343-350
48. Welner CP, Thompson MIB (1988) Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy. Am J Obstet Gynecol 158:570-573
49. Wellens JHH, Durrer D (1973) Effect of digitalis on atrioventricular conduction and circus movement tachycardia in patients with the Wolff-Parkinson-White syndrome. Circulation 47:1229-1236
50. Younis JS, Granat M (1987) Insufficient transplacental digoxin transfer in severe hydrops fetalis. Am J Obstet Gynecol 157:1268-1269
51. Rein, AJ, O'Donnell, C, Geva, T, Nir, A, Pereles, Z, Hashimoto, Li, XK, Sahn, DJ (2002) Use of tissue velocity imaging in the diagnosis of fetal cardiac arrhythmias. Circulation 106: 1827-1833